NCT06672991

Brief Summary

Chronic calculous cholecystitis in pediatric patients leads to choledocholithiasis in about 12% of cases. These patients require removal of stones from the common bile duct. The most common method of cleaning the common bile duct is endoscopic retrograde cholangiopancreatography, and the standard technique for removing the gallbladder is laparoscopic cholecystectomy. There are different approaches to the treatment of this category of patients: laparoscopic common bile duct exploration (LCBDE), laparoendoscopic rendezvous method (LERV) and one-stage LC after ERCP. Given the inflammation of the gallbladder and the inflammatory process in the hepatoduodenal ligament, early laparoscopic cholecystectomy can lead to various intraoperative complications. The aim of this retrospective study is to evaluate the efficacy and safety of endoscopic retrograde cholangiopancreatography, endoscopic sphincterotomy with laparoscopic cholecystectomy in a delayed manner (single or repeated hospitalization).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 31, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 4, 2024

Completed
17 days until next milestone

Study Start

First participant enrolled

November 21, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 4, 2025

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 5, 2025

Completed
Last Updated

February 7, 2025

Status Verified

February 1, 2025

Enrollment Period

3 months

First QC Date

October 31, 2024

Last Update Submit

February 5, 2025

Conditions

Keywords

ChildrenEndoscopic retrograde cholangiopancreatography (ERCP)СholedocholelysisCommon Bile Duct Calculi

Outcome Measures

Primary Outcomes (1)

  • Recurrence of common bile duct stones

    The diagnosis of the stone in the common bile duct was made by MRI, CT scan and ultrasound, if confirmed, before performing laparoscopic cholecystectomy.

    60 days after ERCP

Secondary Outcomes (10)

  • Bleeding

    30 days after ERCP

  • Perforation

    30 days after ERCP

  • Bile leak

    30 days after ERCP

  • Acute cholangitis

    60 days after ERCP

  • Bile duct stricture

    1 year after ERCP

  • +5 more secondary outcomes

Study Arms (2)

ERCP, EST and LC in one hospitalization

Procedure: Endoscopic retrograde cholangiopancreatography;laparoscopic cholecystectomy

ERCP, EST and LC on rehospitalization

Procedure: Endoscopic retrograde cholangiopancreatography;laparoscopic cholecystectomy

Interventions

Initially, ERCP with EST was performed by an endoscopist with the consent of the patient or legal representative. The patients underwent endoscopic procedures using fluoroscopy in the operating room, under general anesthesia. Subsequently, laparoscopic cholecystectomy was performed on a delayed basis, 7 to 15 days after ERCP in a single hospitalization

ERCP, EST and LC in one hospitalization

Eligibility Criteria

Age0 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

children under 18 years of age diagnosed with cholecystocholedocholithiasis

You may qualify if:

  • Informed consent from child or legal guardian
  • Age 0-18 years
  • Acute cholecystitis
  • Choledocholithiasis

You may not qualify if:

  • Unwillingness or inability to consent to the study
  • Previous ERCP or percutaneous transhepatic biliary drainage
  • Benign or malignant stricture
  • Preoperative comorbidities: gastrointestinal bleeding, severe liver disease, acute and chronic cholangitis, septic shock.
  • In combination with Mirizzi syndrome and intrahepatic bile duct stones
  • Congenital anomaly of the biliary tract
  • Malignant neoplasms
  • Acute pancreatitis before the procedure

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Moscow Regional Scientific Research Clinical Institute named after M.F. Vladimirsky

Moscow, Moscow Oblast, 142636, Russia

Location

MeSH Terms

Conditions

CholedocholithiasisCholecystolithiasisGallstones

Condition Hierarchy (Ancestors)

Common Bile Duct DiseasesBile Duct DiseasesBiliary Tract DiseasesDigestive System DiseasesCholelithiasisGallbladder DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Dmitriy А Pyhteev, PhD

    Moscow Regional Scientific Research Clinical Institute named after M.F. Vladimirsky

    STUDY DIRECTOR
  • Leonid M Elin

    Moscow Regional Scientific Research Clinical Institute named after M.F. Vladimirsky

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 31, 2024

First Posted

November 4, 2024

Study Start

November 21, 2024

Primary Completion

February 4, 2025

Study Completion

February 5, 2025

Last Updated

February 7, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will share

A complete dataset can be provided upon reasoned request

Locations